Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DR9Y | ISIN: US03782L1017 | Ticker-Symbol: 910
Tradegate
21.01.25
15:36 Uhr
31,890 Euro
-0,110
-0,34 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
APPIAN CORPORATION Chart 1 Jahr
5-Tage-Chart
APPIAN CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
32,06032,34007:57
32,07032,39007:51
PR Newswire
375 Leser
Artikel bewerten:
(2)

Appian Unveils Latest Platform Release for Better Process and Better Outcomes

Finanznachrichten News

New enhancements scale high-volume workflows and increase efficiency and analysis with AI

LONDON, Dec. 3, 2024 /PRNewswire/ -- Appian (Nasdaq: APPN) today announced its latest platform release, which delivers process automation powered by enterprise AI. Appian helps organisations design, automate, and optimise business processes and this release introduces new features across the platform, making it faster and easier to understand, interact with, and explore data within applications. This release introduces Appian Autoscale and enhanced AI insights, giving organisations better operational efficiency, scalability, and process performance. Appian was already the scalability leader. Now, with Autoscale, Appian enables customers to scale six million processes per hour, 10x more than Appian's previous benchmark.

Appian 24.4

Appian Autoscale lets organisations scale high-volume, straight-through processes, whether handling real-time claims validation, continuous transaction monitoring, credit risk scoring, or other high-throughput processes. With Autoscale, users can easily scale new or existing processes and monitor performance with tools that give insight into millions of process instances. A detailed process history also helps identify and resolve issues quickly, ensuring smooth operations even during high demand.

Helia, a leading Lenders Mortgage Insurance (LMI) provider in Australia, uses the Appian Platform to automate processes and create an interconnected workplace. By automating claims management, Helia reduced processing time from two days to under 10 minutes, enhancing the lender experience. Helia evaluated Appian Autoscale during its beta program earlier this year.

"We achieved all of our application scale and performance goals with Appian Autoscale," said Bharat Marwaha, Automation Platform Leader, Helia.

Additional generative AI enhancements in Appian's latest release include:

  • Multiple AI features achieve FedRAMP Moderate compliance. Now all AI Skills and most AI Copilot features are FedRAMP compliant. These features meet the stringent security, privacy, and operational requirements for public sector use, enabling more government agencies to automate complex processes with confidence.

  • Simpler data extraction with AI Skills. Appian's document extraction AI now automatically detects and consolidates multi-page tables, streamlining data extraction and eliminating the need for manual workarounds. Once you've completed the reconciliation step, future table extractions will happen automatically, further improving efficiency.

  • Quicker response times and a better overall experience with AI Copilot for data fabric. Now fully released, AI Copilot delivers up to 40% faster response times, gives you real-time progress updates, and supports up to 250 record types. Appian's data fabric now also enables more precise filtering and immediate sync recovery for automatic data updates after failed syncs.

  • Process insights AI now includes AI Copilot for faster creation of business-specific KPIs and insight summaries. Get a fresh perspective on your processes with AI-detection for ad hoc events, suggestions for KPIs, and insight summaries for improvements. These easy-to-apply AI use cases provide practical, measurable AI value that enhances collaboration, streamlines decision-making, and improves operational efficiency.

"As organisations grow, they must rapidly scale operations and turn ideas into actionable strategies to stay competitive," said Michael Beckley, CTO and Founder of Appian. "With Appian Autoscale and our AI capabilities, enterprises can build resilient and adaptable processes that respond instantly. By embedding agentic AI that autonomously responds to stimuli within structured processes, Appian enables AI to use data effectively. This approach enables seamless collaboration between human and digital systems to drive actions for maximised returns."

About Appian

Appian is a software company that orchestrates business processes. The Appian Platform empowers leaders to design, automate, and optimise important processes from start to finish. With our industry-leading platform and commitment to customer success, Appian is trusted by top organisations to drive transformational process change. For more information, visit appian.com. [Nasdaq: APPN]

Follow Appian: LinkedIn, X (Twitter)

Appian helps organizations build apps and workflows rapidly, with a low-code automation platform. Combining people, technologies, and data in a single workflow, Appian can help companies maximize their resources and improve business results. Many of the world's largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance. To learn more, visit www.appian.com.

Photo - https://mma.prnewswire.com/media/2571925/Appian_24_4.jpg
Logo - https://mma.prnewswire.com/media/1488235/Appian_Caption_2700px_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/appian-unveils-latest-platform-release-for-better-process-and-better-outcomes-302320699.html

© 2024 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.